Daniel Häusermann

Daniel Häusermann specializes in public and private M&A, equity capital markets (ECM) and real estate transactions. He also advises on corporate and capital markets law and corporate governance. He has been partner at Homburger since 2021 and Co-head of the Healthcare/Life Sciences team since 2024. Daniel Häusermann is also a professor (Titularprofessor) of private and business law at the University of St. Gallen and has authored two books and over 40 articles

• Advised ADC Therapeutics on its USD 100 m and USD 60 m private placements of common shares and pre-funded warrants
  
  
• Advised Santhera on its CHF 20 m Royalty Monetization and Convertible Bond Financing
  
  
• Advised Temenos on the sale of its fund administration software business to Montagu Private Equity
  
  
• Advised Liberty Global and Sunrise on the spin-off of Sunrise and listing of Sunrise on the SIX and NASDAQ
  
  
• Advised Meyer Burger on its CHF 206.75 m rights offering

• Capital markets: Equity
• M&A
• Private equity

• Automotive
• Healthcare
• Industrials
• Pharmaceutical and life sciences
• Real estate
• Technology and telecommunications

• Switzerland (2008)

• Swiss Bar Association
• Zurich Bar Association
• Chair of the Advisory Board, Capital Markets and Technology Association (CMTA)
• Regional Committee Member Switzerland, German-American Lawyers’ Association (DAJV)
• Sustaining Member, European Law Institute (ELI)

• Professor (Titularprofessor) of Private and Business Law, University of St. Gallen, Switzerland (2021)
• Private Reader (Privatdozent) for private and business law, University of St. Gallen (2015)
• LL.M., Harvard Law School (2011)
• Dr. iur., University of St. Gallen (2009)
• lic. iur. HSG, University of St. Gallen (2005)